Le Roy C Dowey
Overview
Explore the profile of Le Roy C Dowey including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
114
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Logue C, Dowey L, Verhagen H, Strain J, OMahony M, Kapsokefalou M, et al.
J Nutr
. 2020 Jul;
150(9):2435-2441.
PMID: 32678445
Background: Observational investigations into the health impacts of low-calorie sweeteners (LCSs) in humans fail to adequately identify or fully characterize LCS consumption. Objectives: We aimed to utilize a novel biomarker...
2.
Davies M, Kalsi G, Armour C, Jones I, McIntosh A, Smith D, et al.
Behav Res Ther
. 2019 Nov;
123:103503.
PMID: 31715324
Background: Anxiety and depression are common, debilitating and costly. These disorders are influenced by multiple risk factors, from genes to psychological vulnerabilities and environmental stressors, but research is hampered by...
3.
Ding X, Bucholc M, Wang H, Glass D, Wang H, Clarke D, et al.
Sci Rep
. 2018 Jun;
8(1):9774.
PMID: 29950585
There is currently a lack of an efficient, objective and systemic approach towards the classification of Alzheimer's disease (AD), due to its complex etiology and pathogenesis. As AD is inherently...
4.
Logue C, Dowey L, Strain J, Verhagen H, McClean S, Gallagher A
J Agric Food Chem
. 2017 May;
65(22):4516-4525.
PMID: 28506059
Although the use of low-calorie sweeteners (LCSs) is widespread, methods of assessing consumption within free-living populations have inherent limitations. Five commonly consumed LCSs, namely, acesulfame-K, saccharin, sucralose, cyclamate, and steviol...
5.
McNulty H, Dowey L, Strain J, Dunne A, Ward M, Molloy A, et al.
Circulation
. 2005 Dec;
113(1):74-80.
PMID: 16380544
Background: Meta-analyses predict that a 25% lowering of plasma homocysteine would reduce the risk of coronary heart disease by 11% to 16% and stroke by 19% to 24%. Individuals homozygous...